May 16, 2023
Today, we are speaking to Ichor Life Sciences CEO Dr. Kelsey Moody about the doctoral program that the company operates and how the company is supporting the next generation of scientists. Ichor Life Sciences is a biotechnology company that develops and manufactures new medicines for people around the world. It is focused on creating treatments...
May 04, 2023
Research published today in Nature Aging has described a machine learning algorithm that finds senescent cell-removing drugs (senolytics) and compared the algorithm's discoveries to existing compounds. A quest for effective therapeutics What Are Senolytics? Senotherapeutics for Senescent CellsSenolytics work by targeting one of several pro-survival pathways that senescent cells use to evade apoptosis and cling...
August 22, 2022
On August 22, 2022, Lifespan.io Executive Director Stephanie Dainow will participate in the Decentralized Science and Blockchain session as a part of the Emerging Tech Workshop at the world’s largest annual Aging Research and Drug Discovery conference (9th ARDD). Stephanie Dainow is the Executive Director at Lifespan.io. Stephanie Dainow has a lifelong passion for longevity...
July 13, 2022
A new study conducted by Insilico Medicine in collaboration with leading aging research institutions has identified novel therapeutic targets for amyotrophic lateral sclerosis, a devastating age-associated neurodegenerative disease [1]. Disease and aging: not that different Amyotrophic lateral sclerosis (ALS) is a rare neuromuscular disease. It is most famous for afflicting the well-known physicist Stephen Hawking,...
November 02, 2021
A study published in EBioMedicine has shown how a peptide targets and kills senescent cancer cells, potentially paving the way for a new class of interventions. Why we Age: Cellular SenescenceAs your body ages, more of your cells become senescent. Senescent cells do not divide or support the tissues of which they are part; instead,...
August 11, 2021
A recent study published in Aging Cell has turned up potential new therapeutics to target the aging extracellular matrix (ECM). Longevity drug discovery The discovery of new targets injects fresh lifeblood into the race to develop anti-aging compounds. The strategies used to identify these targets have seen significant innovation recently, with various types of databases...
